Offer - Urjas Oil for just ₹ 1 X
Bortrac 2 Mg Injection is a prescription drug, available for use as Injection. Multiple Myeloma are some of its major therapeutic uses. Secondary and off-label uses of Bortrac 2 Mg Injection have also been mentioned below.
The optimal dosage of Bortrac 2 Mg Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Bortrac 2 Mg Injection can also lead to other problems, which have been listed below. Such side effects of Bortrac 2 Mg Injection normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Bortrac 2 Mg Injection's effect during pregnancy is Severe and Severe while nursing. In addition, Bortrac 2 Mg Injection's effects on the liver, heart and kidney are discussed below in the Bortrac 2 Mg Injection related warnings section.
Bortrac 2 Mg Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Gastrointestinal Bleeding are examples of such conditions. The section on Bortrac 2 Mg Injection contraindications lists all such conditions.
Additionally, Bortrac 2 Mg Injection may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Bortrac 2 Mg Injection is not safe while driving, and is is not addictive in nature.
Bortrac 2 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Bortrac 2 Mg Injection safe for pregnant women?
Bortrac should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Bortrac 2 Mg Injection safe during breastfeeding?
Taking Bortrac may lead to serious side effects if you are breastfeeding. Bortrac should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Bortrac 2 Mg Injection on the Kidneys?
Bortrac does not damage the kidneys.
What is the effect of Bortrac 2 Mg Injection on the Liver?
You may experience side effects on your liver after taking Bortrac. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Bortrac 2 Mg Injection on the Heart?
Bortrac may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Bortrac 2 Mg Injection unless your doctor advises you to do so -
Is this Bortrac 2 Mg Injection habit forming or addictive?
No, there is no any evidence that Bortrac 2 Mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Bortrac 2 Mg Injection. So it is best to avoid driving.
Is it safe?
Yes, but consume Bortrac 2 Mg Injection only on doctor's advice.
Is it able to treat mental disorders?
No, Bortrac 2 Mg Injection is not used to treat mental disorders.
Interaction between Food and Bortrac 2 Mg Injection
Taking Bortrac 2 Mg Injection with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Bortrac 2 Mg Injection
It is difficult to say anything about the effect of Bortrac 2 Mg Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 234-235
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Velcade® (bortezomib)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bortezomib Aft (Bortezomib)